Endoscopic imaging in inflammatory bowel disease: current developments and emerging strategiesvan der Laan, J. J. H., van der Waaij, A. M., Gabriëls, R. Y., Festen, E. A. M., Dijkstra, G. & Nagengast, W. B., 2020, In : Expert Review of Gastroenterology & Hepatology. p. 1-12 12 p.
Research output: Contribution to journal › Article › Academic › peer-review
INTRODUCTION: Developments in enhanced and magnified endoscopy have signified major advances in endoscopic imaging of ileocolonic pathology in inflammatory bowel disease (IBD). Artificial intelligence is increasingly being used to augment the benefits of these advanced techniques. Nevertheless, treatment of IBD patients is frustrated by high rates of non-response to therapy, while delayed detection and failures to detect neoplastic lesions impede successful surveillance. A possible solution is offered by molecular imaging, which adds functional imaging data to mucosal morphology assessment through visualizing biological parameters. Other label-free modalities enable visualization beyond the mucosal surface without the need of tracers.
AREAS COVERED: A literature search up to May 2020 was conducted in PubMed/MEDLINE in order to find relevant articles that involve the (pre-)clinical application of high-definition white light endoscopy, chromoendoscopy, artificial intelligence, confocal laser endomicroscopy, endocytoscopy, molecular imaging, optical coherence tomography, and Raman spectroscopy in IBD.
EXPERT OPINION: Enhanced and magnified endoscopy have enabled an improved assessment of the ileocolonic mucosa. Implementing molecular imaging in endoscopy could overcome the remaining clinical challenges by giving practitioners a real-time in vivo view of targeted biomarkers. Label-free modalities could help optimize the endoscopic assessment of mucosal healing and dysplasia detection in IBD patients.
|Number of pages||12|
|Journal||Expert Review of Gastroenterology & Hepatology|
|Publication status||E-pub ahead of print - 2020|